1-3 of 3
Linus Angenendt
Close
Sort by
Journal Articles

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears

Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, Lars Haalck, Jörg Gromoll, Stefan Schlatt, Rita Exeler, Annalen Bleckmann, Georg Lenz, Sebastian Wolf, Björn Steffen, Wolfgang E. Berdel, Christoph Schliemann, Benjamin Risse, Linus Angenendt
Journal: Blood Advances
Blood Adv (2023) 8 (1): 70–79.
https://doi.org/10.1182/bloodadvances.2023011076
Published: 2023
Includes: Supplemental data
Journal Articles

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

Clinical Trials & Observations
Andrew F. Berdel, Leo Ruhnke, Linus Angenendt, Martin Wermke, Christoph Röllig, Jan-Henrik Mikesch, Annika Scheller, Teresa Hemmerle, Mattia Matasci, Klaus Wethmar, Torsten Kessler, Mirjam Gerwing, Daniel Hescheler, Michael Schäfers, Wolfgang Hartmann, Bianca Altvater, Claudia Rossig, Martin Bornhäuser, Georg Lenz, Matthias Stelljes, Bjoern Rueter, Dario Neri, Wolfgang E. Berdel, Christoph Schliemann
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3684–3696.
https://doi.org/10.1182/bloodadvances.2021006909
Published: 2022
Includes: Supplemental data
Journal Articles

Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML

Clinical Trials & Observations
Linus Angenendt, Marius Wöste, Jan-Henrik Mikesch, Maria Francisca Arteaga, Adrian Angenendt, Sarah Sandmann, Wolfgang E. Berdel, Georg Lenz, Martin Dugas, Soheil Meshinchi, Christoph Schliemann, Claudia Rössig
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4413–4421.
https://doi.org/10.1182/bloodadvances.2021005236
Published: 2021
Includes: Supplemental data